BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 307266)

  • 1. [Inter-alpha-trypsin inhibitor in serum and bronchial mucus inhibitor in sputum in chronic airway obstruction (author's transl)].
    Rasche B; Hochstrasser K; Ulmer WT
    Respiration; 1978; 36(1):39-47. PubMed ID: 307266
    [No Abstract]   [Full Text] [Related]  

  • 2. [Free and combined protease inhibitors in bronchial mucus in patients with extended chronic obstructive airway diseases (author's transl)].
    Hochstrasser K; Rasche B; Reichert R; Hochgesand K
    Pneumonologie; 1974; 150(2-4):253-9. PubMed ID: 4419015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protease and antiprotease activity in sputum and broncho-alveolar smears in healthy subjects and in inflammatory diseases of the lungs].
    Bogadel'nikov IV; Protsenko VA; Egorychev VE; Gorishniak LKh
    Pediatriia; 1985 Jul; (7):74-7. PubMed ID: 2413421
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mucous membrane specific protease inhibitors in bronchial mucus in severe chronic obstructive bronchitis and in alpha 1-antitrypsin deficiency syndrome].
    Rasche B; Hochstrasser K; Marcic I; Ulmer WT
    Respiration; 1975; 32(5):340-54. PubMed ID: 1080869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proteolytic enzymes and their inhibitors in bronchopulmonary diseases (a review of the literature)].
    Veremeenko KN; Kizim AI
    Vrach Delo; 1985 Jul; (7):34-8. PubMed ID: 3901514
    [No Abstract]   [Full Text] [Related]  

  • 6. [Elastase and elastase inhibitors in bronchial mucus in chronic airway obstruction with reference to therapy].
    Rasche B; Hochstrasser K
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():725-7. PubMed ID: 6557570
    [No Abstract]   [Full Text] [Related]  

  • 7. [About the question of simultaneously occuring proteolytic and antiproteolytic activity in sputum in case of obstructive airway diseases (author's transl)].
    Hochstrasser K; Hochgesand K; Rasche B
    Respiration; 1974; 31(4):343-9. PubMed ID: 4842829
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proteases and their inhibitors in the pathogenesis of pulmonary emphysema].
    Tishkin OG
    Arkh Patol; 1979; 41(3):66-70. PubMed ID: 311629
    [No Abstract]   [Full Text] [Related]  

  • 9. [Possibilities for inactivation of protease activity in sputum by protease inhibitors in chronic obstructive airway diseases].
    Rasche B; Ulmer WT
    Res Exp Med (Berl); 1972; 158(3):229-45. PubMed ID: 4117560
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibitors of proteases in bronchial secretion of patients deficient in alpha-l-antitrypsin].
    Laine A; Lebas J; Hayem A
    Lille Med; 1976 Feb; 21(2):140-3. PubMed ID: 1084948
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitor activity against elastolytic enzymes in the bronchial area. A contribution to the pathogenesis of chronic airway obstruction.
    Rasche B
    Z Erkr Atmungsorgane; 1985; 165(1):83-93. PubMed ID: 3851611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Introduction to a study of the hydrosoluble proteins of the sputum (author's transl)].
    Scrobogna S; Trani S; Predominato M; Novello E
    Ann Sclavo; 1976; 18(2):357-63. PubMed ID: 1087870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteases and protease inhibitors in chronic obstructive lung disease.
    Erikson S
    Acta Med Scand; 1978; 203(6):449-55. PubMed ID: 78661
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiproteolytic potential of the blood serum in chronic nonspecific lung diseases].
    Kaminskaia GO; Zhukova NL; Ozerova LB
    Sov Med; 1986; (10):77-81. PubMed ID: 2433771
    [No Abstract]   [Full Text] [Related]  

  • 15. The biochemical pathogenesis of chronic obstructive pulmonary diseases: protease-antiprotease imbalance in emphysema and diseases of the airways.
    Kuhn C
    J Thorac Imaging; 1986 Mar; 1(2):1-6. PubMed ID: 3298671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arterial blood gas tensions and airways obstruction in normal subjects and patients with obstructive lung disease before and during adaptation to altitude (author's transl)].
    Hartmann B; Unger M; Debelić M; Hilpert P
    Respiration; 1974 Jan; 31(1):7-20. PubMed ID: 4810262
    [No Abstract]   [Full Text] [Related]  

  • 17. [The protease-inhibitor capacity of human bronchial mucus. Content in low molecular inhibitor and 1 -antitrypsin under physiological and physiopathological conditions].
    Reichert R; Hochstrasser K; Conradi G
    Pneumonologie; 1972; 147(1):13-20. PubMed ID: 5083256
    [No Abstract]   [Full Text] [Related]  

  • 18. [The change concentrations in the serum of immunoglobulins and alpha-1 atitrypsin in children with obstructive pulmonary diseases].
    Miljković D; Dzelebcjić J; Kostić N
    Srp Arh Celok Lek; 1995; 123(5-6):116-9. PubMed ID: 17974450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of chronic, bronchial hypersecretion (author's transl)].
    Puchelle E; Girard F; Polu JM; Aug F; Sadoul P
    Pathol Biol (Paris); 1978 Oct; 26(7):441-51. PubMed ID: 372900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical-functional emphysema diagnostics and immunological correlations (author's transl)].
    Kowalski J; Rasche B; Bulgalho de Almeida AA; Hochstrasser K; Ulmer WT
    Klin Wochenschr; 1979 May; 57(10):521-7. PubMed ID: 313477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.